| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 08/24/1999 | US5942413 Polynucleotide fragment that codes an antigen from parasitic worms; antihelmintics |
| 08/24/1999 | US5942406 Inert support material for avidin-biotin affinity based technology |
| 08/24/1999 | CA2082650C Method and apparatus for biopolymer synthesis |
| 08/19/1999 | WO1999041280A1 METHOD FOR PURIFYING PrPres FROM A BIOLOGICAL SAMPLE AND APPLICATIONS |
| 08/19/1999 | WO1999041274A1 A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
| 08/19/1999 | WO1999041273A2 Pna and dna conjugates and methods for preparation thereof |
| 08/19/1999 | WO1999041258A1 Novel dimerizing agents, their production and use |
| 08/19/1999 | WO1999041007A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| 08/19/1999 | CA2319492A1 Novel dimerizing agents, their production and use |
| 08/18/1999 | EP0936565A1 Method of searching database of three-dimensional protein structures |
| 08/18/1999 | EP0935611A1 Serine protease inhibitors |
| 08/18/1999 | EP0935609A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
| 08/18/1999 | EP0935606A1 Method for purification of recombinant proteins |
| 08/18/1999 | EP0910474A4 Absorption-enhanced differential extraction device |
| 08/18/1999 | EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/18/1999 | CN1226176A Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 08/18/1999 | CN1226174A Use of proteinase inhibitors for prevention or reduction of bone resorption |
| 08/18/1999 | CN1044709C Method for crystallizing itnerferon alpha-2 |
| 08/17/1999 | US5940307 Method for predicting the tendency of a protein to form amphiphilic αβ structure |
| 08/17/1999 | US5939550 Preparing acid-addition salt of prodrug acid of naphthyridinone antibiotic by treating ester of compound with protic acid, condensing intermediate with dipeptide, subjecting n-protected prodrug ester to acid hydrolysis |
| 08/17/1999 | US5939523 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 08/17/1999 | US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents |
| 08/17/1999 | US5939384 Antibiotics as antifungal compounds and antiprotozoa agents |
| 08/17/1999 | US5939304 Reacting active serine of thrombin with enzyme inhibitor; alkali treatment at ph not less than 11; recovering product in presence of polyhydric alcohols, saccharides, and salt or amphoteric electrolyte preventing coagulation |
| 08/17/1999 | US5939274 Immunological binding antibodies or fragments capable of specifically binding to peptide fragment derived from bone collagen |
| 08/17/1999 | US5939273 Incubating galactosyl epitope labeled combinatorial library members with cellular or protein targets, washing away non-specifically bound members, incubating with anti-galactosyl antibodies for detectable signal; complement cascade |
| 08/17/1999 | US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens |
| 08/17/1999 | US5939268 Diels-alder reaction product of a diene and a dienophile; chemical intermediates for drugs, solid phase synthesis |
| 08/17/1999 | US5939023 Fibrinogen processing apparatus method and container |
| 08/12/1999 | WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations |
| 08/12/1999 | WO1999040182A2 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF |
| 08/12/1999 | WO1999040105A2 Array fabrication methods |
| 08/12/1999 | WO1999039817A1 Method of quality control in manufacturing processes |
| 08/12/1999 | WO1999039739A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
| 08/12/1999 | WO1999028344A3 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 08/12/1999 | WO1999028343A3 Hydrophobically-modified protein compositions and methods |
| 08/12/1999 | WO1999026975A3 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained |
| 08/12/1999 | WO1999024050A9 High throughput method for functionally classifying proteins identified using a genomics approach |
| 08/12/1999 | WO1999021957A9 Method and apparatus for screening catalyst libraries |
| 08/12/1999 | WO1999009417A3 Method of drug selection |
| 08/12/1999 | CA2320947A1 Array fabrication methods |
| 08/12/1999 | CA2320810A1 Method of quality control in manufacturing processes |
| 08/12/1999 | CA2320470A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
| 08/12/1999 | CA2319040A1 Crystalline tnf-.alpha.-converting enzyme and uses thereof |
| 08/11/1999 | EP0934529A1 METHOD TO DETECT $i(DIROFILARIA IMMITIS) INFECTION |
| 08/11/1999 | EP0934337A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma |
| 08/11/1999 | EP0934260A1 N alpha-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids |
| 08/11/1999 | EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods |
| 08/11/1999 | EP0934072A1 Manufacturing process for the production of purified transferrin |
| 08/11/1999 | EP0835323A4 Modified proteins and methods of their production |
| 08/11/1999 | CN1225641A Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e. g. histidine) function |
| 08/10/1999 | US5936092 Fatty acid conjugate containing a disulfide linkage; increased absorption of compounds |
| 08/10/1999 | US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 08/10/1999 | US5936061 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| 08/10/1999 | US5935795 Glial cell line-derived neurotrophic factor antibody |
| 08/10/1999 | US5935601 Acylated peptide as a carrier for oral administration |
| 08/10/1999 | US5935579 A peptide will stimulate proliferation of a t-cell clone in a t-cell proliferation assay and produce an alloepitopic effect, peptide when administered in a tolerizing amount will suppress proliferation of t-cell clone in second assay |
| 08/10/1999 | CA2136208C Improved methods for the preparation of endotoxin-binding proteins |
| 08/10/1999 | CA2126863C Chimeric immunogens |
| 08/10/1999 | CA2070882C A process for large-scale production of antimicrobial peptide in high purity |
| 08/10/1999 | CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use |
| 08/09/1999 | CA2260450A1 Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril |
| 08/05/1999 | WO1999039207A1 Acid cleavable phenoxyalkyl linker for combinatorial synthesis |
| 08/05/1999 | WO1999038990A1 Methods for recovering polypeptides from plants and portions thereof |
| 08/05/1999 | WO1999038888A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
| 08/05/1999 | WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 08/05/1999 | CA2319306A1 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
| 08/04/1999 | EP0933380A1 Method of searching for physiologically active substances and process for producing the same |
| 08/04/1999 | EP0933365A2 Growth hormone secretagogues |
| 08/04/1999 | EP0933083A1 Process for the purification of serum albumin |
| 08/04/1999 | EP0932623A1 Colostrinin, and uses thereof |
| 08/04/1999 | EP0932614A1 Peptide prodrugs containing an alpha-hydroxyacid linker |
| 08/04/1999 | EP0575490B1 GnRH ANALOGS |
| 08/03/1999 | US5933819 Computer-implemented method |
| 08/03/1999 | US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 08/03/1999 | US5932696 Solid phase preparation of amines |
| 08/03/1999 | US5932695 Synthesis of hydroxamic acid derivatives |
| 08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
| 08/03/1999 | US5932476 Cloning of chicken anemia virus DNA |
| 08/03/1999 | US5932433 Biotinylation of proteins |
| 08/03/1999 | US5932212 Crosslinked protein crystal formulations and their use as catalysts in organic solvents |
| 08/03/1999 | US5932102 Determination of hydrophilic index of histidine residues in protein to be purified as a measure of its affinity, optimally adjusting ph of sample solution so that protein binds to chromatography column |
| 08/03/1999 | CA2017039C Gel filtration of heat treated factor viii |
| 08/03/1999 | CA1340689C Human b-cell differentiation factor and process of producing said factor |
| 07/29/1999 | WO1999037705A1 Block polymer processing for mesostructured inorganic oxide materials |
| 07/29/1999 | WO1999037680A1 Purification of fibrinogen |
| 07/29/1999 | WO1999037324A1 Modified enzymes and their use for peptide synthesis |
| 07/29/1999 | CA2318440A1 Purification of fibrinogen |
| 07/28/1999 | EP0931259A2 Matrices with memories in automated drug discovery and units therefor |
| 07/28/1999 | EP0931085A1 Phosphorylating reagents |
| 07/28/1999 | EP0931069A1 Process for preparing amidines |
| 07/28/1999 | EP0931038A1 Novel substance library and supramolecular complexes produced therewith |
| 07/28/1999 | EP0930895A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones |
| 07/28/1999 | EP0880405B1 Device and process for the synthetization of macromolecules |
| 07/28/1999 | EP0852617A4 Apparatus and methods for active programmable matrix devices |
| 07/28/1999 | EP0776330A4 Photolabile compounds and methods for their use |
| 07/27/1999 | US5929214 Porous polymeric monolith is formed by functionalizing/ grafting pores with thermally responsive polymers and copolymers; used as thermal gates, valves and for isocratic hydrophobic interaction chromatography of proteins |
| 07/27/1999 | US5929211 Carbohydrate-directed cross-linking reagents |
| 07/27/1999 | US5929208 Combinatorial synthesis of biopolymers by contacting substrate with solution of monomer a, selectively biasing locations to specifically concentrate monomer a, removing unreacted monomer a, repeating with other monomers |
| 07/27/1999 | US5928896 Genetically engineering a polypeptide that mimics sweet or taste modifier peptide; different length but contains interaction site flanked by prolines |